IVF vs TSLA
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 12, 2026
IVF
TSLA
Investment Advisor Scores
TSLA
AI Analyst Insights
Detailed Metrics Comparison
| Metric | IVF | TSLA | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 153.8462 | Tie |
| PEG Ratio | 0 | 4.397 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 16.7% | 25.5% | TSLA |
| Earnings Growth | 0.0% | -3.0% | IVF |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 43.0/100 | 39.0/100 | IVF |
| Profit Margin | -70.2% | 3.7% | TSLA |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | SELL | IVF |
Relative Price Performance (Last 90 Days)
Current Technical Phase
IVF
MarkdownPrice below a falling SMA50 (slope -16.0%), weak momentum, RSI 43
TSLA
NeutralMixed signals - no dominant trend phase, RSI 54
Fundamentals Snapshot
| Metric | IVF | TSLA |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -0.1 | 169.3 |
| Trailing P/E | 0.0 | 346.2 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.3% |
| Gross Margin | 0.4% | 0.2% |
| Operating Margin | -0.6% | 0.0% |
| EPS | 363.47 | 1.05 |
| Dividend Yield | — | — |